Published in Nucleic Acids Res on April 11, 2006
DNA binding, nucleotide flipping, and the helix-turn-helix motif in base repair by O6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapy. DNA Repair (Amst) (2007) 1.36
Flap endonucleases pass 5'-flaps through a flexible arch using a disorder-thread-order mechanism to confer specificity for free 5'-ends. Nucleic Acids Res (2012) 1.06
A novel DNA damage recognition protein in Schizosaccharomyces pombe. Nucleic Acids Res (2006) 0.98
Alkyltransferase-like proteins: molecular switches between DNA repair pathways. Cell Mol Life Sci (2010) 0.92
Atl1 regulates choice between global genome and transcription-coupled repair of O(6)-alkylguanines. Mol Cell (2012) 0.90
Alkyltransferase-like protein (Atl1) distinguishes alkylated guanines for DNA repair using cation-π interactions. Proc Natl Acad Sci U S A (2012) 0.89
The nitrosated bile acid DNA lesion O6-carboxymethylguanine is a substrate for the human DNA repair protein O6-methylguanine-DNA methyltransferase. Nucleic Acids Res (2013) 0.83
Synthesis and characterization of an O(6)-2'-deoxyguanosine-alkyl-O(6)-2'-deoxyguanosine interstrand cross-link in a 5'-GNC motif and repair by human O(6)-alkylguanine-DNA alkyltransferase. Org Biomol Chem (2010) 0.76
Copper carbenes alkylate guanine chemoselectively through a substrate directed reaction. Chem Sci (2016) 0.75
MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer (2004) 3.27
Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res (2000) 3.05
Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis (2004) 3.02
DNA binding and nucleotide flipping by the human DNA repair protein AGT. Nat Struct Mol Biol (2004) 2.86
Isolation and structural characterization of a cDNA clone encoding the human DNA repair protein for O6-alkylguanine. Proc Natl Acad Sci U S A (1990) 2.19
Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci U S A (1990) 2.14
O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. Bioessays (2002) 1.58
Variability and regulation of O6-alkylguanine-DNA alkyltransferase. Carcinogenesis (2003) 1.54
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. J Clin Oncol (2002) 1.50
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res (2006) 1.45
Pyridyloxobutyl adduct O6-[4-oxo-4-(3-pyridyl)butyl]guanine is present in 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone-treated DNA and is a substrate for O6-alkylguanine-DNA alkyltransferase. Chem Res Toxicol (1997) 1.38
High-resolution structure of a mutagenic lesion in DNA. Proc Natl Acad Sci U S A (1990) 1.38
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma. J Clin Oncol (1998) 1.32
O6-alkylguanine-DNA alkyltransferase assay. Methods Mol Biol (2000) 1.20
2-amino-O4-benzylpteridine derivatives: potent inactivators of O6-alkylguanine-DNA alkyltransferase. J Med Chem (2004) 1.09
Inactivation of O6-alkylguanine-DNA alkyltransferase. 1. Novel O6-(hetarylmethyl)guanines having basic rings in the side chain. J Med Chem (1998) 1.03
Structural features of substituted purine derivatives compatible with depletion of human O6-alkylguanine-DNA alkyltransferase. J Med Chem (1992) 1.00
The synthesis of oligoribonucleotides containing N6-alkyladenosines and 2-methylthio-N6-alkyladenosines via post-synthetic modification of precursor oligomers. Nucleic Acids Res (2003) 0.99
Inhibition of O6-methylguanine-DNA methyltransferase by an alkyltransferase-like protein from Escherichia coli. Nucleic Acids Res (2005) 0.97
Synthesis of oligodeoxynucleotides containing analogs of O6-methylguanine and reaction with O6-alkylguanine-DNA alkyltransferase. Biochemistry (1994) 0.95
Substituted O6-benzylguanine derivatives and their inactivation of human O6-alkylguanine-DNA alkyltransferase. J Med Chem (1994) 0.95
8-Substituted O6-benzylguanine, substituted 6(4)-(benzyloxy)pyrimidine, and related derivatives as inactivators of human O6-alkylguanine-DNA alkyltransferase. J Med Chem (1995) 0.93
Synthesis and reactions of 6-methylsulfonyl-9-beta-D-ribofuranosylpurine. J Org Chem (1975) 0.91
Facile synthesis of O6-alkyl-, O6-aryl-, and diaminopurine nucleosides from 2'-deoxyguanosine Org Lett (2000) 0.90
Bacterial and mammalian DNA alkyltransferases sensitize Escherichia coli to the lethal and mutagenic effects of dibromoalkanes. Carcinogenesis (1997) 0.88
O6-(alkyl/aralkyl)guanosine and 2'-deoxyguanosine derivatives: synthesis and ability to enhance chloroethylnitrosourea antitumor action. J Med Chem (1997) 0.86
O6-alkylguanine-DNA alkyltransferase inactivation in cancer chemotherapy. Mini Rev Med Chem (2003) 0.84
Inactivation of human O(6)-alkylguanine-DNA alkyltransferase by modified oligodeoxyribonucleotides containing O(6)-benzylguanine. J Pharmacol Exp Ther (2001) 0.82
Monosaccharide-linked inhibitors of O(6)-methylguanine-DNA methyltransferase (MGMT): synthesis, molecular modeling, and structure-activity relationships. J Med Chem (2001) 0.79
A comparison of Internet and print-based physical activity interventions. Arch Intern Med (2007) 3.18
Acute Affective Response to a Moderate-intensity Exercise Stimulus Predicts Physical Activity Participation 6 and 12 Months Later. Psychol Sport Exerc (2008) 2.33
Late outcomes following open and endovascular repair of blunt thoracic aortic injury. J Vasc Surg (2010) 2.28
Social-cognitive determinants of physical activity: the influence of social support, self-efficacy, outcome expectations, and self-regulation among participants in a church-based health promotion study. Health Psychol (2006) 2.17
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol Ther (2005) 1.82
Flipping of alkylated DNA damage bridges base and nucleotide excision repair. Nature (2009) 1.70
Mycoplasma infection significantly alters microarray gene expression profiles. Biotechniques (2003) 1.66
FDI Vision 2020: shaping the future of oral health. Int Dent J (2012) 1.63
Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting. Int J Radiat Oncol Biol Phys (2006) 1.48
Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg (2006) 1.47
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res (2006) 1.45
Billions with oral disease: A global health crisis-a call to action. J Am Dent Assoc (2015) 1.42
Social cognitive mediators of change in a group randomized nutrition and physical activity intervention: social support, self-efficacy, outcome expectations and self-regulation in the guide-to-health trial. J Health Psychol (2010) 1.40
Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI. Virol J (2006) 1.38
Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. Clin Cancer Res (2005) 1.37
Mediators of physical activity behavior change: a multivariate approach. Health Psychol (2008) 1.35
Early open and endovascular thoracic aortic repair for complicated type B aortic dissection. Ann Thorac Surg (2013) 1.31
Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma. J Clin Oncol (2007) 1.29
Step into Motion: a randomized trial examining the relative efficacy of Internet vs. print-based physical activity interventions. Contemp Clin Trials (2007) 1.28
Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients. J Clin Invest (2011) 1.27
Intravascular ultrasound in the diagnosis and treatment of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol (2002) 1.26
O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy. Br Med Bull (2008) 1.21
Targeting O⁶-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy. Cell Mol Life Sci (2010) 1.20
A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer. Int J Cancer (2002) 1.20
Operative delay for peripheral malperfusion syndrome in acute type A aortic dissection: a long-term analysis. J Thorac Cardiovasc Surg (2008) 1.18
Hybrid debranching with endovascular repair for thoracoabdominal aneurysms: a comparison with open repair. Ann Thorac Surg (2010) 1.15
Reducing inequalities in oral disease. Br Dent J (2011) 1.13
Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway. Lancet Oncol (2003) 1.12
Flap endonucleases pass 5'-flaps through a flexible arch using a disorder-thread-order mechanism to confer specificity for free 5'-ends. Nucleic Acids Res (2012) 1.06
Cost Analysis of Internet vs. Print Interventions for Physical Activity Promotion. Psychol Sport Exerc (2010) 1.05
Common celiacomesenteric trunk: aneurysmal and occlusive disease. J Vasc Surg (2004) 1.05
Targeting human 8-oxoguanine DNA glycosylase (hOGG1) to mitochondria enhances cisplatin cytotoxicity in hepatoma cells. Carcinogenesis (2007) 1.04
The effect of tautomeric constant on the specificity of nucleotide incorporation during DNA replication: support for the rare tautomer hypothesis of substitution mutagenesis. J Mol Biol (2003) 1.02
A comparison of open and endovascular descending thoracic aortic repair in patients older than 75 years of age. Ann Thorac Surg (2008) 1.01
Late outcomes of endovascular aortic repair for the infected thoracic aorta. Ann Thorac Surg (2009) 1.01
A novel mitochondrial K(ATP) channel assay. Circ Res (2010) 1.00
Tear size and location impacts false lumen pressure in an ex vivo model of chronic type B aortic dissection. J Vasc Surg (2008) 1.00
The impact of incentives on exercise behavior: a systematic review of randomized controlled trials. Ann Behav Med (2014) 1.00
Criminal justice involvement, behavioral health service use, and costs of forensic assertive community treatment: a randomized trial. Community Ment Health J (2010) 0.98
An outline of the foundations of systematics and biogeography. Hist Philos Life Sci (2007) 0.98
A novel DNA damage recognition protein in Schizosaccharomyces pombe. Nucleic Acids Res (2006) 0.98
Nuclear targeting of Porphyromonas gingivalis W50 protease in epithelial cells. Infect Immun (2002) 0.98
Inhibition of O6-methylguanine-DNA methyltransferase by an alkyltransferase-like protein from Escherichia coli. Nucleic Acids Res (2005) 0.97
Feasibility of using computer-tailored and internet-based interventions to promote physical activity in underserved populations. Telemed J E Health (2010) 0.96
Sequence-specific cleavage of RNA in the absence of divalent metal ions by a DNAzyme incorporating imidazolyl and amino functionalities. Nucleic Acids Res (2004) 0.96
Long-term results from a 12-year experience with endovascular therapy for thoracic aortic disease. Ann Thorac Surg (2006) 0.95
Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4. Mol Ther (2004) 0.94
Clinical problem-solving. A sinister development--a 35-year-old woman presented to the emergency department with a 2-day history of progressive swelling and pain in her left leg, without antecedent trauma. N Engl J Med (2007) 0.94
Dual repair modulation reverses Temozolomide resistance in vitro. Mol Cancer Ther (2004) 0.94
Long-term results of percutaneous management of malperfusion in acute type B aortic dissection: implications for thoracic aortic endovascular repair. J Thorac Cardiovasc Surg (2009) 0.94
YMCA commit to quit: randomized trial outcomes. Am J Prev Med (2012) 0.92
Aortic intimal tears: detection with spiral computed tomography. J Endovasc Ther (2003) 0.92
Amino-functionalized DNA: the properties of C5-amino-alkyl substituted 2'-deoxyuridines and their application in DNA triplex formation. Nucleic Acids Res (2005) 0.92
Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells. Cancer Res (2008) 0.92
Aortic intussusception complicating diagnostic angiography: recognition and management. Ann Thorac Surg (2013) 0.92
Transluminal hypogastric artery occlusion with an Amplatzer vascular plug during endovascular aortic aneurysm repair. J Vasc Surg (2008) 0.91
A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2. J Vasc Surg (2006) 0.91
Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg (2007) 0.90
Effect of O6-(4-bromothenyl)guanine on different temozolomide schedules in a human melanoma xenograft model. Int J Cancer (2002) 0.90
DNA alkylation and repair in the large bowel: animal and human studies. J Nutr (2002) 0.90
Yoga as a complementary treatment for smoking cessation: rationale, study design and participant characteristics of the Quitting-in-Balance study. BMC Complement Altern Med (2010) 0.90
Atl1 regulates choice between global genome and transcription-coupled repair of O(6)-alkylguanines. Mol Cell (2012) 0.90
A comparative analysis of open and endovascular repair for the ruptured descending thoracic aorta. J Vasc Surg (2009) 0.89
Mediators of physical activity behavior change: findings from a 12-month randomized controlled trial. Health Psychol (2011) 0.89
Aging and the social cognitive determinants of physical activity behavior and behavior change: evidence from the guide to health trial. J Aging Res (2011) 0.89
Treatment for malperfusion syndrome in acute type A and B aortic dissection: A long-term analysis. J Thorac Cardiovasc Surg (2010) 0.89
Yoga as a complementary treatment for smoking cessation in women. J Womens Health (Larchmt) (2011) 0.89
Alkyltransferase-like protein (Atl1) distinguishes alkylated guanines for DNA repair using cation-π interactions. Proc Natl Acad Sci U S A (2012) 0.89
Obesity and hepatosteatosis in mice with enhanced oxidative DNA damage processing in mitochondria. Am J Pathol (2011) 0.89
Ulcerlike projections developing in noncommunicating aortic dissections: CT findings and natural history. AJR Am J Roentgenol (2009) 0.89
Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomide. Hum Gene Ther (2004) 0.88
Convenient and efficient syntheses of oligodeoxyribonucleotides containing O(6)-(carboxymethyl)guanine and O(6)-(4-oxo-4-(3-pyridyl)butyl)guanine. Nucleosides Nucleotides Nucleic Acids (2012) 0.87
Survival benefit of endovascular descending thoracic aortic repair for the high-risk patient. Ann Thorac Surg (2007) 0.87
Interstrand disulfide crosslinking of DNA bases supports a double nucleotide unpairing mechanism for flap endonucleases. Chem Commun (Camb) (2012) 0.86
Elevated N3-methylpurine-DNA glycosylase DNA repair activity is associated with lung cancer. Mutat Res (2012) 0.86
The challenge of associated intramural hematoma with endovascular repair for penetrating ulcers of the descending thoracic aorta. J Vasc Surg (2010) 0.86
Healthy for life: a randomized trial examining physical activity outcomes and psychosocial mediators. Ann Behav Med (2013) 0.86
Tumor O(6)-methylguanine-DNA methyltransferase inactivation by oral lomeguatrib. Clin Cancer Res (2010) 0.85
Oral health professionals and social determinants. Br Dent J (2013) 0.85
Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC->AT transition mutations in a population exposed to methylating agents. Carcinogenesis (2004) 0.85
Endovenous laser ablation: venous outcomes and thrombotic complications are independent of the presence of deep venous insufficiency. J Vasc Surg (2008) 0.84
Association between lung cancer risk and single nucleotide polymorphisms in the first intron and codon 178 of the DNA repair gene, O6-alkylguanine-DNA alkyltransferase. Int J Cancer (2008) 0.84